Awardee OrganizationUNIVERSITY OF ALABAMA AT BIRMINGHAM
Description
Abstract Text
DESCRIPTION (Adapted from the Applicant's Abstract): The CFTR chloride channel
is implicated in two major human diseases: cystic fibrosis (low CFTR activity)
and secretory diarrhea (excessive CFTR activity). The development of rational
treatment strategies for either disease requires a better understanding of what
activates or inactivates the CFTR channel. Although it is clear that CFTR is
stimulated by PKA-mediate phosphorylation of the large regulatory domain (R
domain) within this channel, the mechanisms that control CFTR gating are still
obscure. Two new paradigms of CFTR regulation will be explored: 1) the
stabilization of CFTR channel activity by an intramolecular interaction between
the amino-terminal tail (N-tail) and the R domain and 2) the coupling of CFTR
gating to the membrane traffic machinery by an intermolecular interaction
between the CFTR N-tail and syntaxin 1A. These paradigms will be explored by
pursuing three Specific Aims. First, the mechanism by which the N-tail
stabilizes CFTR channel activity will be defined. Subaims include testing the
hypothesis that the N-tail controls channel gating by modulating the
phosphorylation of key residues within the R domain. Second, the structural
basis of the interaction between the N-tail and R domain will be defined. The
nature of the physical interaction between these domains will be characterized
and the hypothesis that CFTR channel gating can be disrupted by peptides that
block this interdomain interaction will be tested. Third, the hypothesis that
CFTR channel gating is regulated by interactions between this ion channel will
be tested and that components of the membrane traffic machinery coordinate the
regulation of ion transport and protein traffic in epithelial cells. The
results of the proposed study should provide new information regarding the
mechanisms that control the activity of the CFTR chloride channel; information
that may lead to more effective strategies for manipulating CFTR function in
diseases that involve this ion channel.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
063690705
UEI
YND4PLMC9AN7
Project Start Date
01-September-2000
Project End Date
31-August-2005
Budget Start Date
01-September-2000
Budget End Date
31-August-2001
Project Funding Information for 2000
Total Funding
$306,481
Direct Costs
$225,000
Indirect Costs
$81,481
Year
Funding IC
FY Total Cost by IC
2000
National Institute of Diabetes and Digestive and Kidney Diseases
$306,481
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01DK056796-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01DK056796-01A1
Patents
No Patents information available for 1R01DK056796-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01DK056796-01A1
Clinical Studies
No Clinical Studies information available for 1R01DK056796-01A1
News and More
Related News Releases
No news release information available for 1R01DK056796-01A1
History
No Historical information available for 1R01DK056796-01A1
Similar Projects
No Similar Projects information available for 1R01DK056796-01A1